Tele: 561.316.3330
Breaking Medical Device News

Wednesday, October 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR

December 6, 2020: BVI, one of the fastest-growing diversified companies in ophthalmology, today announced it has acquired Arcadophtha SARL (Arcad), a France-based ophthalmic company specializing in silicon oils, gases and perfluorocarbons used in vitreoretinal surgery. Growth of the Arcad products will be accelerated through BVI’s broad-reaching commercial infrastructure established with the Vitreq line of vitreoretinal surgical products.

The transaction has closed during the 4th quarter of 2019 and financial terms of the transaction were not disclosed.  Arcad was acquired from its founders, who will continue to support the business.

“We are pleased to welcome the Arcad team to our organization. The products fit extremely well alongside our current vitreoretinal product offering.  Arcad’s unmatched focus on product quality and vertically-integrated business model aligns well with BVI’s business philosophy,” said Shervin Korangy, President and CEO of BVI. “Vitreoretinal surgery is a strategic segment for BVI and Arcad’s products will further strengthen our ability to meet the needs of our customers.”

Arcad has developed a proprietary process of purification and fractionation that delivers high-quality products for use by surgeons. Additionally, the company has developed certain single-use and easy to administer delivery systems for products.  Arcad brings over 25 years of expertise in the ophthalmic space and a strong history in close collaboration with surgeons worldwide.

“We are thrilled to partner with BVI and firmly believe that our combined offering of physician-preferred products will continue to contribute to outstanding patient outcomes,” said Gerard Reboul, Co-founder of Arcad. “BVI’s emphasis on innovative and differentiated products culturally aligns with our organization.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced...

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

By using this website you agree to accept Medical Device News Magazine Privacy Policy